AAO: Genentech provides update on presentations, product portfolio

Video

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.


Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Arshad M. Khanani, MD, MA, FASRS, shares GA results from the GATHER2 extension trial during the 2025 American Academy of Ophthalmology meeting
Durga Borkar, MD, a vitreoretinal surgeon at Duke University, speaks about avacincaptad pegol for geographic atrophy treatment, the topic of her American Academy of Ophthalmology (AAO) presentation.
© 2025 MJH Life Sciences

All rights reserved.